MaxLinear enters the final week of August with a sharp internal contradiction: the stock bounced 5.7% on Tuesday after falling 8.6% over the prior week, yet the founder and CEO just sold more than $21 million of stock near the highs — and options traders are the most defensively positioned they've been in months.
The most striking signal this week is the options market. The put/call ratio has jumped to 0.51, roughly two and a half standard deviations above its 20-day average of 0.43 — the most defensive options read in the past year outside of the 52-week high of 0.96. That's a meaningful shift. For most of the past month the PCR sat comfortably in a narrow range around 0.41, so the last two sessions represent a genuine step-change in how the options market is leaning. The move coincides almost exactly with the price reversal from highs near $85.
The lending market tells a much calmer story. Short interest of roughly 4.9% of the float is modest, and borrow availability is extraordinarily loose — currently more than 6,000% of short interest, near the widest level of the past 30 days and well above even the 52-week tightest reading of 1,390%. Cost to borrow has ticked up 27% on the week to 0.45%, but that's still negligible in absolute terms. There is no squeeze dynamic building here. The ORTEX short score of 35.4 reflects a mildly elevated short setup, though SI itself has crept up roughly 5% over the week and about the same over the past month — a slow, steady rebuild rather than anything aggressive.
The insider move is harder to ignore. MaxLinear's founder, Chairman and CEO Kishore Seendripu sold approximately 353,000 shares on August 17 across multiple transactions totalling just over $21 million, at prices ranging from roughly $84.60 to $88.10. That was near a local peak before the stock sold off. Seendripu still holds around 4.6 million shares, and the 90-day net across all insiders shows net selling of about $55 million — substantial for a company of this size. Planned-trading programmes can explain single transactions, but the scale here warrants attention alongside the price weakness that followed.
On the Street, the backdrop is more constructive than the recent price action implies. Following the July earnings print, analysts broadly lifted targets — Stifel raised to $120, Roth Capital and Needham both moved to $100, and even Wells Fargo's neutral stance came with a target raise to $95. The consensus mean target is near $94.50, implying roughly 42% upside from Tuesday's close of $66.36. Bulls point to MaxLinear's positioning in high-speed broadband and data center interconnect, with 90-day forward EPS momentum ranking in the 91st percentile across the ORTEX universe. Bears flag the July 23 earnings event — the stock fell 17.5% the following day and lost nearly 23% over the subsequent five sessions — as evidence that the market remains sceptical about the cadence of AI-driven demand for the Panther product, and that pending arbitration from a terminated acquisition creates an unquantified liability overhang. The EV/EBITDA of 29x is not cheap for a name that still carries execution risk.
The peer group has also been weak. INTC dropped 9.5% over the week, MKSI fell 9.9%, and COHU lost 14.5%. MXL's 8.6% weekly decline puts it roughly in line with the cohort — this was sector-wide pressure rather than stock-specific pain. AMD was the relative bright spot, off just 1.1%.
With the next earnings event pencilled in for October 21, the next month-and-a-half sets up as a period where the stock's path depends heavily on any data points around AI infrastructure spending timelines and broadband capex commitments — the same variables that drove the outsized post-earnings reaction in July.
See the live data behind this article on ORTEX.
Open MXL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
